Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
Rankning i aktier
#4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Aktiekurs
$3.89
Marknadsvärde
$3.30B
Förändring (1 dag)
-3.14%
Förändring (1 år)
43.11%
Land
CN
Handel Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Kategori
Healthcare
Aktiekurshistorik för Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Högsta slutkurs: $3.82 den 2026-10-01
Lägsta slutkurs: $1.20 den 2009-12-01
Lägsta slutkurs: $1.20 den 2009-12-01
Aktiekurshistorik för Guangdong Zhongsheng Pharmaceutical Co., Ltd. från 2009 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | 9.67% |
| 2025 | 69.73% |
| 2024 | -25.78% |
| 2023 | -48.47% |
| 2022 | 174.43% |
| 2021 | -13.29% |
| 2020 | 27.55% |
| 2019 | 16.87% |
| 2018 | -33.33% |
| 2017 | 5.53% |
| 2016 | -9.41% |
| 2015 | 26.15% |
| 2014 | -5.92% |
| 2013 | 29.15% |
| 2012 | 45.26% |
| 2011 | -24.39% |
| 2010 | -0.74% |
| 2009 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
